Purchase Order 75N95022P00028

Award Date 11/29/21
Potential Completion Date 11/28/24
Potential Value $546K
Funding Federal Agency
National Institute on Aging
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to the University of Exeter, a public research university in the United Kingdom, is for $24,750.00 to provide laboratory support services related to the quantification of Phenserine in human plasma samples. The contract was awarded by the National Institute on Aging, a civilian agency, and does not have a set-aside designation. The University of Exeter has a single-award indefinite delivery contract (IDV) with the National Institute on Aging valued at $1,988,692...
The University of Exeter was awarded a $962,486 delivery order contract by the National Institute on Aging (NIA) to conduct a clinical evaluation of a phenserine tartrate extended-controlled release tablet (ECRT) formulation. The contract, which has a period of performance ending on January 31, 2026, is for services related to evaluating the efficacy of the investigational treatment for early mild Alzheimer's disease and mild to moderate traumatic brain injury. The contract is a cost-no-fee...
This firm fixed-price purchase order contract was awarded by the National Eye Institute (NEI), a component of the National Institutes of Health (NIH), to UK Biobank Limited, a non-profit organization. The $11,630.34 contract provides access to UK Biobank's large-scale biomedical database containing genetic, lifestyle, and health information from over 500,000 UK participants. This biobank serves as a research resource for approved scientific studies, and the contract facilitates projects...
The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a $12,000 firm fixed price purchase order to UK Biobank Limited. The purpose of this contract is to provide Dr. Stewart and his team access to biobank data including whole exome and genome data on 500,000 individuals linked to electronic health records within UK Biobank. This will support analysis of the frequency, phenotypic spectrum, and penetrance...
This federal contract award, valued at $11,550.24, was issued by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health (NIH), to UK Biobank Limited, a non-profit organization based in the United Kingdom. The contract is for a 36-month extension to provide Tier 3 level access to UK Biobank's large-scale biomedical database, which contains de-identified genetic, lifestyle, and health information from over 500,000 participants in the UK. This...
The National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism awarded UK Biobank Limited a three-year, firm fixed price purchase order valued at approximately thirteen thousand three hundred eighty-eight U.S. dollars to provide access to the United Kingdom Biobank dataset. As the prime contractor, UK Biobank Limited will deliver its biomedical database of genetic and health information to support research efforts of the National Institute on Alcohol Abuse and Alcoholism....
This is a $12,120 firm fixed-price purchase order awarded by the National Cancer Institute, part of the National Institutes of Health, to UK Biobank Limited, a non-profit organization. The contract provides UK Biobank Limited's large-scale biomedical database containing de-identified genetic, lifestyle, and health information from over 500,000 UK participants as a research resource for approved scientific researchers to analyze. The award, with a completion date of February 6, 2026,...
UK Biobank Limited has been awarded a $13,500 purchase order by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, to provide laboratory and testing services. The firm fixed price contract runs from December 2023 through March 2026 and will be performed by UK Biobank in Great Britain. No additional details were provided on the original solicitation or work scope. The award does not appear to be associated with a...
This firm fixed price purchase order was awarded by the National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism to the University of Bristol, doing business as Avon Longitudinal Study of Parents and Children, to provide 1100 hours of statistical work. The solicitation sought these services to analyze data from the long-running Avon Longitudinal Study of Parents and Children cohort linked to fatty acid and trace metal analyses provided by NIH. Specifically, the work...
The Department of Health and Human Services National Institutes of Health National Institute on Alcohol Abuse and Alcoholism awarded a $35,000 firm fixed price purchase order to the University of Bristol doing business as Alspac (Children of the 90s) for statistical services. The contract has a period of performance from August 21, 2017 through August 23, 2018 for work to be conducted in Great Britain, United Kingdom. No additional details were provided regarding the original solicitation or...

The University of Exeter has been awarded a $546,052 firm fixed-price purchase order by the National Institutes of Health National Institute on Aging to provide epidemiology and statistical analysis services supporting a research project utilizing United Kingdom Biobank data. The solicitation sought quotations for two epidemiologists/statisticians and one postdoctoral scholar experienced in analyzing UK Biobank data to develop analysis plans, perform statistical analyses, and interpret findings regarding the roles of mitochondrial dysfunction and brain iron deposition in Alzheimer's disease progression. The contract objectives align with NIH's focus on better understanding neurodegenerative diseases. Work will be performed by the University of Exeter in the United Kingdom over a potential three-year period from November 2021 through November 2024, with no set-aside designation specified.

Generated 12/29/23, 3:19 PM